Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Capital Expenditures (2016 - 2021)

Cavitation Technologies (CVAT) has disclosed Capital Expenditures for 8 consecutive years, with $250000.0 as the latest value for Q3 2021.

  • Quarterly Capital Expenditures rose 233.33% to $250000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $253000.0 through Sep 2022, down 16.5% year-over-year, with the annual reading at $128000.0 for FY2021, 156.0% up from the prior year.
  • Capital Expenditures hit $250000.0 in Q3 2021 for Cavitation Technologies, up from $3000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $250000.0 in Q3 2021 to a low of $1000.0 in Q2 2019.
  • Historically, Capital Expenditures has averaged $71500.0 across 3 years, with a median of $50000.0 in 2020.
  • Biggest five-year swings in Capital Expenditures: soared 4900.0% in 2020 and later crashed 94.0% in 2021.
  • Year by year, Capital Expenditures stood at $1000.0 in 2019, then skyrocketed by 4900.0% to $50000.0 in 2020, then soared by 400.0% to $250000.0 in 2021.
  • Business Quant data shows Capital Expenditures for CVAT at $250000.0 in Q3 2021, $3000.0 in Q2 2021, and $50000.0 in Q4 2020.